Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-04-16FDA Approved: LORATADINE — Original Application (Chain Drug Consortium, LLC)
The FDA approved the original application for loratadine filed by Chain Drug Consortium, LLC, enabling a generic loratadine product to be ma…
-
FDA approval · 2018-04-16FDA Approved: LORATADINE — Original Application (Wal-Mart Stores, Inc)
FDA approves Wal-Mart Stores, Inc.'s original ANDA for loratadine (generic antihistamine) to treat allergy symptoms.
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber [Phase 1]
Phase 1 study evaluating innate neutrophilic nasal inflammation in allergic rhinitis using a pollen exposure chamber has completed.
-
FDA approval · 2018-04-11FDA Approved: LORATADINE ODT — Original Application (Aurohealth LLC)
FDA approved a generic loratadine orally disintegrating tablet (LORATADINE ODT) under ANDA 208477 with Aurohealth LLC as the sponsor. The pr…
-
FDA approval · 2018-04-02FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) filed by Chattem, Inc. The action confirms changes to the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-03-30FDA Approved: QNASL — Supplemental Application (Teva Respiratory, LLC)
The FDA approved a supplemental application for QNASL (beclomethasone dipropionate) submitted by Teva Respiratory, LLC.
-
FDA approval · 2018-03-26FDA Approved: ASMANEX HFA — Supplemental Application (Organon LLC)
FDA approved a supplemental NDA for ASMANEX HFA (mometasone furoate) from Organon LLC, authorizing changes via a supplemental application.
-
CLINICAL_TRIALS trial_result · 2018-03-26Clinical Trial Update: Sanfu Herbal Patch and Sanfu Moxibustion for Persistent Allergic Rhinitis: a Controlled Clinical Trial [Phase 2]
A Phase 2 controlled clinical trial update evaluating the Sanfu Herbal Patch and Sanfu Moxibustion for persistent allergic rhinitis.
-
CLINICAL_TRIALS research · 2018-03-22Clinical Trial Update: The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis [NA]
A completed clinical trial from Mahidol University investigates how common local allergic rhinitis is in children and describes its clinical…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Inhibitory Receptors in Eosinophils of Atopic Subjects
This completed clinical trial examined inhibitory receptors on eosinophils from atopic subjects to understand immunoregulation in allergic d…
-
FDA approval · 2018-03-19FDA Approved: XHANCE — Supplemental Application (OptiNose US, Inc.)
FDA approved a supplemental application for XHANCE (fluticasone propionate) submitted by OptiNose US, Inc. The approval is categorized as a …
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean [Phase 3]
A Phase 3 clinical trial evaluating the safety and efficacy of AGR Tablet for perennial allergic rhinitis in Korean patients has completed.
-
FDA approval · 2018-02-26FDA Approved: ADVIL ALLERGY AND CONGESTION RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approves a supplemental application to market ADVIL ALLERGY AND CONGESTION RELIEF, a fixed-dose combination product containing chlorphen…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections [Phase 1]
A Phase 1 trial evaluating the safety of Ragweed Mix administered by intralymphatic node injections for allergic conjunctivitis and allergic…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract [Phase 2]
Phase 2 study evaluating the biological standardization of Dermatophagoides pteronyssinus allergen extract has completed.
-
FDA approval · 2018-02-15FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin chewable grape and bubblegum formulations (loratadine) from Bayer HealthCare LLC. This …
-
FDA approval · 2018-02-06FDA Approved: CLARINEX-D 12 HOUR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for CLARINEX-D 12 HOUR, a desloratadine and pseudoephedrine sulfate combination product from Org…
-
CLINICAL_TRIALS trial_result · 2018-01-29Clinical Trial Update: Fluticasone Nasal Spray Patient Preference Study [Phase 3]
Phase 3 patient-preference study of Fluticasone nasal spray in allergic rhinitis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2018-01-29Clinical Trial Update: The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation [Phase 4]
Pilot Phase 4 trial evaluating Grass SLIT treatment for birch pollen–induced allergic rhinitis; completed with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-26Clinical Trial Update: Traditional Chinese Medicine on Gut Microbiota and Allergic Diseases [Phase 3]
Phase 3 clinical trial evaluating traditional Chinese medicine on gut microbiota for allergic rhinitis.
-
FDA approval · 2018-01-19FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for NASACORT ALLERGY 24HR (Triamcinolone Acetonide) from Chattem, Inc.
-
FDA approval · 2018-01-19FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Dr. Reddy's Laboratories Inc.)
The FDA approved Dr. Reddy's Laboratories' original ANDA for levocetirizine dihydrochloride, a generic antihistamine indicated for relief of…
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX® [Phase 4]
A Phase 4 clinical trial update on molecular and cellular mechanisms in allergic rhinitis patients treated with GRAZAX.
-
FDA approval · 2018-01-12FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental application for Claritin (loratadine) filed by Bayer HealthCare LLC. This action confirms a supplemental approva…
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen [Phase 2]
Phase 2 trial update evaluating two doses of AllerT for allergic rhinitis due to birch pollen; completed study.